FATE THERAPEUTICS INC (FATE)

Latest Insider Confidence Score

2026Q1

49.9
Bearish

Company insider confidence (by quarter)

2013Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
RedCo II Master Fund, L.P. — 8,977,624 Jul 3, 2025
Venrock Associates V Lp 10% Owner 570,663 Oct 7, 2013
Venrock Partners V L P 10% Owner 570,663 Oct 7, 2013
Venrock Entrepreneurs Fund V, L.P. 10% Owner 570,663 Oct 7, 2013
Venrock Management V, LLC 10% Owner 570,663 Oct 7, 2013

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 15, 2026 Jan 16, 2026 TAHL CINDY Officer Neutral 90.0 +100,000 25.83% ✗ -
Jan 15, 2026 Jan 16, 2026 Adawi Kamal CFO Neutral 90.0 +25,000 33.33% ✗ -
Jan 15, 2026 Jan 16, 2026 Valamehr Bahram CEO Neutral 90.0 +335,000 101.61% ✗ -
Jan 9, 2026 Jan 12, 2026 TAHL CINDY Officer Sell 46.3 -10,589 -2.66% ✗ $11.3K
Jan 9, 2026 Jan 12, 2026 Valamehr Bahram CEO Sell 47.5 -5,190 -1.55% ✗ $5.6K
Oct 20, 2025 Oct 21, 2025 Adawi Kamal CFO Neutral 90.0 +75,000 100.00% ✗ -
Oct 21, 2025 Adawi Kamal CFO Neutral 52.5 - 0.00% ✗ -
Aug 4, 2025 Aug 5, 2025 TAHL CINDY Officer Sell 47.5 -9,037 -2.22% ✗ $9.6K
Aug 4, 2025 Aug 5, 2025 Valamehr Bahram CEO Sell 46.3 -14,466 -4.14% ✗ $15.4K
Jul 3, 2025 RedCo II Master Fund, L.P. Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Lee Michael Stewart Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Redmile Group, LLC Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Xu Yuan Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Mozaffarian Neelufar Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 RASTETTER WILLIAM H Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 MENDLEIN JOHN Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Jooss Karin Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 EPSTEIN ROBERT S Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 ABERNETHY MATT Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Agarwal Shefali Director Neutral 52.5 - 0.00% ✗ -
May 30, 2025 ABERNETHY MATT Director Neutral 52.5 - 0.00% ✗ -
Jan 16, 2025 Jan 16, 2025 Valamehr Bahram CEO Neutral 52.5 - 0.00% ✗ -
Jan 15, 2025 Jan 16, 2025 TAHL CINDY Officer Neutral 90.0 +70,000 20.79% ✗ -
Jan 15, 2025 Jan 16, 2025 Bressi Jerome Charles Officer Neutral 90.0 +65,000 24.06% ✗ -
Jan 10, 2025 Jan 13, 2025 Bressi Jerome Charles Officer Sell 47.5 -5,980 -2.17% ✗ $9.3K
Jan 10, 2025 Jan 13, 2025 TAHL CINDY Officer Sell 47.5 -5,654 -1.65% ✗ $8.8K
Jan 10, 2025 Jan 13, 2025 Valamehr Bahram CEO Sell 46.3 -8,705 -2.43% ✗ $13.4K
Dec 20, 2024 Dec 26, 2024 Redmile Group, LLC Director Buy 65.0 +56,331 0.44% ✗ $94.6K
Dec 12, 2024 Dec 16, 2024 Redmile Group, LLC Director Neutral 52.5 - 0.00% ✗ -
Aug 21, 2024 Bressi Jerome Charles Officer Neutral 52.5 - 0.00% ✗ -
Aug 6, 2024 Aug 7, 2024 Xu Yuan Director Sell 37.5 -633 -6.80% ✓ $2.7K
Jul 29, 2024 Jul 31, 2024 Valamehr Bahram Chief R&D Officer Neutral 90.0 +200,000 126.53% ✗ -
Jul 29, 2024 Jul 31, 2024 Mozaffarian Neelufar Director Neutral 52.5 - 0.00% ✗ -
Jul 29, 2024 Jul 31, 2024 TAHL CINDY General Counsel and Secretary Neutral 90.0 +200,000 140.49% ✗ -
Jul 31, 2024 Mozaffarian Neelufar Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 11, 2024 Lee Michael Stewart Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 11, 2024 Redmile Group, LLC Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 11, 2024 RASTETTER WILLIAM H Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 11, 2024 Jooss Karin Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 11, 2024 COUGHLIN TIMOTHY Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 11, 2024 Agarwal Shefali Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 11, 2024 Xu Yuan Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 11, 2024 EPSTEIN ROBERT S Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 11, 2024 MENDLEIN JOHN Director Neutral 52.5 - 0.00% ✗ -
Mar 21, 2024 Mar 25, 2024 Redmile Group, LLC Director Neutral 52.5 - 0.00% ✗ -
Mar 4, 2024 Mar 5, 2024 Dulac Edward J III CFO Sell 45.0 -2,447 -2.35% ✓ $19K
Feb 1, 2024 Feb 2, 2024 Wolchko J Scott CEO Neutral 52.5 - 0.00% ✗ -
Feb 1, 2024 Feb 2, 2024 TAHL CINDY General Counsel and Secretary Neutral 52.5 - 0.00% ✗ -
Feb 1, 2024 Feb 2, 2024 Dulac Edward J III CFO Neutral 52.5 - 0.00% ✗ -
Feb 1, 2024 Feb 2, 2024 Valamehr Bahram Chief R&D Officer Neutral 52.5 - 0.00% ✗ -
Jan 29, 2024 Jan 30, 2024 Dulac Edward J III CFO Sell 50.0 -1,849 -1.75% ✓ $9.2K
Jan 9, 2024 Jan 10, 2024 TAHL CINDY General Counsel and Secretary Sell 46.3 -10,874 -7.10% ✗ $47.5K
Jan 9, 2024 Jan 10, 2024 Valamehr Bahram Chief R&D Officer Sell 46.3 -11,271 -6.66% ✗ $49.4K
Jan 9, 2024 Jan 10, 2024 Wolchko J Scott CEO Sell 42.5 -14,391 -3.73% ✗ $62.9K
Jan 9, 2024 Jan 10, 2024 Dulac Edward J III CFO Sell 46.3 -7,028 -6.23% ✗ $30.7K
Jan 2, 2024 Jan 3, 2024 Dulac Edward J III CFO Sell 41.3 -5,182 -4.39% ✓ $19K
Dec 26, 2023 Dec 28, 2023 Redmile Group, LLC Director Buy 60.0 +44,630 0.11% ✗ $166K
Dec 18, 2023 Dec 19, 2023 Dulac Edward J III CFO Sell 50.0 -1,585 -1.33% ✓ $5.5K
Nov 9, 2023 Nov 13, 2023 TAHL CINDY General Counsel and Secretary Sell 25.0 -24,363 -13.72% ✓ $58.5K
Aug 18, 2023 Aug 21, 2023 Dulac Edward J III CFO Sell 46.3 -4,718 -3.80% ✗ $13.2K
Aug 4, 2023 Aug 7, 2023 Xu Yuan Director Sell 37.5 -632 -6.36% ✓ $2.3K
Jul 5, 2023 Jul 6, 2023 Powl Brian T. Chief Commercial Officer Sell 46.3 -3,854 -8.56% ✗ $18.8K
Jul 5, 2023 Jul 6, 2023 Dulac Edward J III CFO Sell 41.3 -5,182 -4.00% ✓ $25K
Jun 14, 2023 Jun 15, 2023 Xu Yuan Director Sell 13.8 -3,460 -25.83% ✓ $19.3K
Jun 6, 2023 Jun 8, 2023 Redmile Group, LLC Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2023 Jun 8, 2023 Lee Michael Stewart Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2023 Jun 7, 2023 Xu Yuan Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2023 Jun 7, 2023 RASTETTER WILLIAM H Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2023 Jun 7, 2023 MENDLEIN JOHN Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2023 Jun 7, 2023 Jooss Karin Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2023 Jun 7, 2023 HERSHBERG ROBERT Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2023 Jun 7, 2023 EPSTEIN ROBERT S Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2023 Jun 7, 2023 COUGHLIN TIMOTHY Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2023 Jun 7, 2023 Agarwal Shefali Director Neutral 52.5 - 0.00% ✗ -
Apr 20, 2023 Apr 21, 2023 Redmile Group, LLC Director Buy 87.5 +276,639 2.15% ✗ $1.7M
Apr 18, 2023 Apr 19, 2023 Chu Yu-Waye Chief Medical Officer Sell 46.3 -2,532 -1.77% ✗ $16.6K
Apr 13, 2023 Apr 17, 2023 Redmile Group, LLC Director Sell 27.5 -276,639 -0.54% ✗ $1.6M
Feb 6, 2023 Feb 7, 2023 Wolchko J Scott CEO Neutral 52.5 - 0.00% ✗ -
Feb 6, 2023 Feb 7, 2023 Valamehr Bahram Chief R&D Officer Neutral 52.5 - 0.00% ✗ -
Feb 6, 2023 Feb 7, 2023 TAHL CINDY General Counsel and Secretary Neutral 52.5 - 0.00% ✗ -
Feb 6, 2023 Feb 7, 2023 Powl Brian T. Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Feb 6, 2023 Feb 7, 2023 Dulac Edward J III CFO Neutral 52.5 - 0.00% ✗ -
Feb 6, 2023 Feb 7, 2023 Chu Yu-Waye Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 19, 2023 Jan 20, 2023 MENDLEIN JOHN Director Neutral 52.5 - 0.00% ✗ -
Jan 11, 2023 Jan 13, 2023 MENDLEIN JOHN Director Buy 97.5 +124,679 78.87% ✗ $698.1K
Jan 12, 2023 Jan 13, 2023 Valamehr Bahram Chief R&D Officer Neutral 52.5 - 0.00% ✗ -
Jan 10, 2023 Jan 11, 2023 Wolchko J Scott CEO Sell 42.5 -45,907 -10.64% ✗ $240.6K
Jan 10, 2023 Jan 11, 2023 Valamehr Bahram Chief R&D Officer Sell 42.5 -10,917 -6.07% ✗ $57.2K
Jan 10, 2023 Jan 11, 2023 TAHL CINDY General Counsel and Secretary Sell 42.5 -11,553 -6.11% ✗ $60.5K
Jan 10, 2023 Jan 11, 2023 Plavsic Mark Chief Technical Officer Sell 46.3 -3,418 -2.69% ✗ $17.9K
Jan 10, 2023 Jan 11, 2023 Dulac Edward J III CFO Sell 46.3 -7,331 -5.36% ✗ $38.4K
Jan 10, 2023 Jan 11, 2023 Chu Yu-Waye Chief Medical Officer Sell 46.3 -7,825 -5.18% ✗ $41K
Aug 18, 2022 Aug 19, 2022 Dulac Edward J III CFO Sell 42.5 -5,135 -3.62% ✗ $153.1K
Jul 21, 2022 Jul 25, 2022 Wolchko J Scott CEO Sell 40.0 -36,246 -1.63% ✓ $1.2M
Jul 7, 2022 Jul 8, 2022 Valamehr Bahram Chief R&D Officer Sell 26.3 -17,158 -8.71% ✓ $518.7K
Jul 6, 2022 Jul 7, 2022 Valamehr Bahram Chief R&D Officer Sell 37.5 -7,842 -4.18% ✓ $235.8K
Jul 5, 2022 Jul 6, 2022 Plavsic Mark Chief Technical Officer Sell 42.5 -3,719 -2.84% ✗ $91.5K
Jun 27, 2022 Jun 29, 2022 Powl Brian T. Chief Commercial Officer Neutral 90.0 +45,000 100.00% ✗ -
Jun 29, 2022 Powl Brian T. Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jun 9, 2022 Jun 13, 2022 Redmile Group, LLC Director Neutral 55.0 +8,650 0.07% ✗ -